Qualitative and Quantitative Evaluation of an Innovative Primary and Secondary Diabetes Clinic in Western Sydney

IF 4.7 Q2 MATERIALS SCIENCE, BIOMATERIALS ACS Applied Bio Materials Pub Date : 2024-02-21 DOI:10.5334/ijic.7548
Sumathy Ravi, G. Meyerowitz-katz, Anandhi Murugesan, J. Ayre, R. Jayaballa, Duncan Rintoul, Marina Sarkis, Kirsten J McCaffery, G. Maberly, C. Bonner
{"title":"Qualitative and Quantitative Evaluation of an Innovative Primary and Secondary Diabetes Clinic in Western Sydney","authors":"Sumathy Ravi, G. Meyerowitz-katz, Anandhi Murugesan, J. Ayre, R. Jayaballa, Duncan Rintoul, Marina Sarkis, Kirsten J McCaffery, G. Maberly, C. Bonner","doi":"10.5334/ijic.7548","DOIUrl":null,"url":null,"abstract":"Introduction: Western Sydney Diabetes (WSD) established an innovative diabetes service in May 2020, using virtual and in-person care, linking primary care with the diabetes specialist team. This study evaluated the service’s feasibility using qualitative and quantitative methods. Method: Evaluation included: 1) thematic analysis of interviews and workshops with patients and health professionals (n = 28); 2) quantitative analysis of records of patients admitted July 2020–June 2021 (n = 110). Results: Key themes related to 1) benefits: convenient location, access to integrated care, advantages of virtual care; 2) challenges: hard for patients to ask questions, technology issues; 3) confidence: shared care decision making, multidisciplinary team; and 4) future directions: additional multidisciplinary services, expanded insulin stabilisation service, promotion. Improvements between baseline and 3 months included 1.3% reduction in HbA1c (p < 0.05). Sulfonylurea dropped by 25% between initial appointment and follow-up, and GLP1RA/SGLT2i use increasing by 30% (p < 0.05). The clinic covered costs using Medicare billings and Nationally Weighted Activity Units. Discussion: The findings suggest this integrated care model was feasible and perceived as beneficial by both patients and providers. The clinic offers a promising model of practice that could be developed further to roll out in other regions for rural delivery of care.","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":"8 12","pages":""},"PeriodicalIF":4.7000,"publicationDate":"2024-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5334/ijic.7548","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Western Sydney Diabetes (WSD) established an innovative diabetes service in May 2020, using virtual and in-person care, linking primary care with the diabetes specialist team. This study evaluated the service’s feasibility using qualitative and quantitative methods. Method: Evaluation included: 1) thematic analysis of interviews and workshops with patients and health professionals (n = 28); 2) quantitative analysis of records of patients admitted July 2020–June 2021 (n = 110). Results: Key themes related to 1) benefits: convenient location, access to integrated care, advantages of virtual care; 2) challenges: hard for patients to ask questions, technology issues; 3) confidence: shared care decision making, multidisciplinary team; and 4) future directions: additional multidisciplinary services, expanded insulin stabilisation service, promotion. Improvements between baseline and 3 months included 1.3% reduction in HbA1c (p < 0.05). Sulfonylurea dropped by 25% between initial appointment and follow-up, and GLP1RA/SGLT2i use increasing by 30% (p < 0.05). The clinic covered costs using Medicare billings and Nationally Weighted Activity Units. Discussion: The findings suggest this integrated care model was feasible and perceived as beneficial by both patients and providers. The clinic offers a promising model of practice that could be developed further to roll out in other regions for rural delivery of care.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
对悉尼西部一家创新型初级和中级糖尿病诊所的定性和定量评估
导言:西悉尼糖尿病中心(WSD)于 2020 年 5 月建立了一项创新型糖尿病服务,采用虚拟和面对面护理的方式,将初级保健与糖尿病专家团队联系起来。本研究采用定性和定量方法对该服务的可行性进行了评估。方法:评估包括1)对患者和医疗专业人员的访谈和研讨会进行主题分析(n = 28);2)对 2020 年 7 月至 2021 年 6 月入院患者的记录进行定量分析(n = 110)。结果:关键主题涉及:1)益处:地点便利、可获得综合护理、虚拟护理的优势;2)挑战:患者难以提问、技术问题;3)信心:共同护理决策、多学科团队;以及 4)未来方向:额外的多学科服务、扩大胰岛素稳定服务、推广。基线与 3 个月之间的改善包括 HbA1c 降低 1.3%(p < 0.05)。磺脲类药物在首次预约和随访期间减少了 25%,GLP1RA/SGLT2i 的使用增加了 30%(p < 0.05)。诊所使用医疗保险账单和全国加权活动单位支付费用。讨论:研究结果表明,这种综合护理模式是可行的,患者和医疗服务提供者都认为这种模式有益。该诊所提供了一种很有前景的实践模式,可以进一步发展,在其他地区的农村地区推广。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
期刊介绍: ACS Applied Bio Materials is an interdisciplinary journal publishing original research covering all aspects of biomaterials and biointerfaces including and beyond the traditional biosensing, biomedical and therapeutic applications. The journal is devoted to reports of new and original experimental and theoretical research of an applied nature that integrates knowledge in the areas of materials, engineering, physics, bioscience, and chemistry into important bio applications. The journal is specifically interested in work that addresses the relationship between structure and function and assesses the stability and degradation of materials under relevant environmental and biological conditions.
期刊最新文献
Plug-and-(Dis)Play Epitope Engineering on Ring-like Particles: Rational Design of Multivalent Immunoreagents for Diagnostics. PEGylated Hemicyanine-Based Dual-Mode Phototherapy Platform with Robust Antibacterial and Antibiofilm Activity against High Priority Pathogens. Correction to "Magnesium Ion/Gallic Acid MOF-Laden Multifunctional Acellular Matrix Hydrogels for Diabetic Wound Healing". Recent Developments in Antimicrobial Hydrogel for Wound Healing. In Vitro and In Vivo Assessment of Darolutamide Encapsulated Lipid-Extruded PEGylated Liposomal Formulation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1